|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.35 USD | -5.31% |
|
-11.20% | +1.74% |
| 06-29 | CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell 2500 Growth Benchmark | CI |
| Market Cap | 5.25B 4.6B 4.24B 3.92B 7.43B 501B 7.55B 50.65B 19.89B 247B 19.73B 19.3B 849B | P/E 2026 * |
-11x | P/E 2027 * | -14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 3.79B 3.31B 3.06B 2.82B 5.35B 361B 5.44B 36.5B 14.33B 178B 14.22B 13.91B 612B | EV / Sales 2026 * |
99.7x | EV / Sales 2027 * | 27.8x |
| Free-Float |
93.98% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CRISPR Therapeutics AG
| 1 day | -5.31% | ||
| 1 week | -11.20% | ||
| Current month | -2.18% | ||
| 1 month | +7.13% | ||
| 3 months | +4.16% | ||
| 6 months | -3.53% | ||
| Current year | +1.74% |
| 1 week | 52.05 |  | 62.8 |
| 1 month | 50.76 | | 63.45 |
| Current year | 44.12 | | 63.45 |
| 1 year | 44.12 | | 78.48 |
| 3 years | 30.04 | | 91.1 |
| 5 years | 30.04 | | 142.64 |
| 10 years | 11.63 | | 220.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samarth Kulkarni
CEO | Chief Executive Officer | 47 | 01/12/2017 |
Raju Prasad
DFI | Director of Finance/CFO | 42 | 14/03/2023 |
Naimish Patel
CTO | Chief Tech/Sci/R&D Officer | - | 28/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Simeon George
BRD | Director/Board Member | 49 | 29/04/2015 |
Ali Behbahani
BRD | Director/Board Member | 49 | 01/04/2015 |
Samarth Kulkarni
CHM | Chairman | 47 | 15/09/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-05 | GSK Equity Investments Ltd.
| Free | Company | 13,000 | 0.0135% | |
| 06-05 | Free | Director | 13,000 | 0.0135% | ||
| 06-05 | Free | Director | 13,000 | 0.0135% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.31% | -11.20% | -6.07% | -7.19% | 5.25B | |
| -0.32% | +0.62% | +3.44% | +9.94% | 50.73B | |
| -2.22% | -1.25% | +391.53% | +593.69% | 39.73B | |
| -0.54% | +0.39% | +27.67% | -5.10% | 34.69B | |
| -1.36% | +0.35% | +19.34% | +55.53% | 33.21B | |
| +1.21% | -4.58% | +3.00% | +31.73% | 26.76B | |
| -1.81% | -1.48% | - | - | 16.8B | |
| +0.51% | -3.47% | +66.38% | +122.57% | 15.37B | |
| +0.44% | +0.82% | +15.13% | +16.91% | 13.78B | |
| -0.62% | -3.09% | +11.43% | -31.02% | 12.85B | |
| Average | -1.00% | -1.87% | +59.09% | +87.45% | 24.92B | |
| Weighted average by Cap. | -0.75% | -0.46% | +80.72% | +121.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.99M 33.23M 30.65M 28.31M 53.72M 3.62B 54.62M 366M 144M 1.78B 143M 140M 6.14B | 153M 134M 123M 114M 216M 14.59B 220M 1.47B 579M 7.19B 574M 562M 24.7B |
| Net income | -481M -421M -388M -359M -680M -45.89B -692M -4.64B -1.82B -22.61B -1.81B -1.77B -77.72B | -373M -326M -301M -278M -528M -35.6B -537M -3.6B -1.41B -17.54B -1.4B -1.37B -60.28B |
| Net Debt | -1.47B -1.28B -1.18B -1.09B -2.07B -140B -2.11B -14.15B -5.56B -68.95B -5.51B -5.39B -237B | -1B -876M -808M -746M -1.42B -95.54B -1.44B -9.66B -3.79B -47.07B -3.76B -3.68B -162B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | $53.35 | -5.31% | 2,074,867 |
| 09/07/26 | $56.34 | -4.83% | 1,436,133 |
| 08/07/26 | $59.20 | -2.58% | 1,226,594 |
| 07/07/26 | $60.77 | -1.81% | 1,668,275 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRSP Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition